FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897300980> ?p ?o ?g. }

• W2897300980 endingPage "934" @default.
• W2897300980 startingPage "922" @default.
• W2897300980 abstract "Here, we report the metabolic profile and the results of associated metabolic studies of 2-hydroxy-acridinone (2-OH-AC), the reference compound for antitumor-active imidazo- and triazoloacridinones.Electrochemistry coupled with mass spectrometry was applied to simulate the general oxidative metabolism of 2-OH-AC for the first time. The reactivity of 2-OH-AC products to biomolecules was also examined. The usefulness of the electrochemistry for studying the reactive drug metabolite trapping (conjugation reactions) was evaluated by the comparison with conventional electrochemical (controlled-potential electrolysis) and enzymatic (microsomal incubation) approaches.2-OH-AC oxidation products were generated in an electrochemical thin-layer cell. Their tentative structures were assigned based on tandem mass spectrometry in combination with accurate mass measurements. Moreover, the electrochemical conversion of 2-OH-AC in the presence of reduced glutathione and/or N-acetylcysteine unveiled the formation of reactive metabolite-nucleophilic trapping agent conjugates (m/z 517 and m/z 373, respectively) through the thiol group. This glutathione S-conjugate was also identified after electrolysis experiment as well as was detected in liver microsomes.Summing up, the present work illustrates that the electrochemical simulation of metabolic reactions successfully supports the results of classical electrochemical and enzymatic studies. Therefore, it can be a useful tool for synthesis of drug metabolites, including reactive metabolites." @default.
• W2897300980 created "2018-10-26" @default.
• W2897300980 creator A5021683319 @default.
• W2897300980 creator A5027301759 @default.
• W2897300980 creator A5033132814 @default.
• W2897300980 creator A5048780500 @default.
• W2897300980 creator A5048901980 @default.
• W2897300980 creator A5088806221 @default.
• W2897300980 date "2019-01-04" @default.
• W2897300980 modified "2023-10-18" @default.
• W2897300980 title "Phase I and phase II metabolism simulation of antitumor-active 2-hydroxyacridinone with electrochemistry coupled on-line with mass spectrometry" @default.
• W2897300980 cites W113358056 @default.
• W2897300980 cites W137896489 @default.
• W2897300980 cites W1494449129 @default.
• W2897300980 cites W1541205806 @default.
• W2897300980 cites W1978342183 @default.
• W2897300980 cites W1992094155 @default.
• W2897300980 cites W1994622550 @default.
• W2897300980 cites W1996935441 @default.
• W2897300980 cites W1997486990 @default.
• W2897300980 cites W2010427019 @default.
• W2897300980 cites W2030501423 @default.
• W2897300980 cites W2030526585 @default.
• W2897300980 cites W2041847326 @default.
• W2897300980 cites W2046687343 @default.
• W2897300980 cites W2047165005 @default.
• W2897300980 cites W2052501240 @default.
• W2897300980 cites W2062080271 @default.
• W2897300980 cites W2064760807 @default.
• W2897300980 cites W2073272057 @default.
• W2897300980 cites W2074374131 @default.
• W2897300980 cites W2090990681 @default.
• W2897300980 cites W2094023685 @default.
• W2897300980 cites W2096565553 @default.
• W2897300980 cites W2101016189 @default.
• W2897300980 cites W2118150120 @default.
• W2897300980 cites W2139683082 @default.
• W2897300980 cites W2151035090 @default.
• W2897300980 cites W2158824143 @default.
• W2897300980 cites W2159301944 @default.
• W2897300980 cites W2165494298 @default.
• W2897300980 cites W2168540406 @default.
• W2897300980 cites W2314919359 @default.
• W2897300980 cites W2317989242 @default.
• W2897300980 cites W2321522369 @default.
• W2897300980 cites W2951677704 @default.
• W2897300980 cites W2951768183 @default.
• W2897300980 cites W4211036490 @default.
• W2897300980 cites W4301762736 @default.
• W2897300980 cites W568586089 @default.
• W2897300980 doi "https://doi.org/10.1080/00498254.2018.1524946" @default.
• W2897300980 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30301406" @default.
• W2897300980 hasPublicationYear "2019" @default.
• W2897300980 type Work @default.
• W2897300980 sameAs 2897300980 @default.
• W2897300980 citedByCount "9" @default.
• W2897300980 countsByYear W28973009802020 @default.
• W2897300980 countsByYear W28973009802021 @default.
• W2897300980 countsByYear W28973009802023 @default.
• W2897300980 crossrefType "journal-article" @default.
• W2897300980 hasAuthorship W2897300980A5021683319 @default.
• W2897300980 hasAuthorship W2897300980A5027301759 @default.
• W2897300980 hasAuthorship W2897300980A5033132814 @default.
• W2897300980 hasAuthorship W2897300980A5048780500 @default.
• W2897300980 hasAuthorship W2897300980A5048901980 @default.
• W2897300980 hasAuthorship W2897300980A5088806221 @default.
• W2897300980 hasConcept C147789679 @default.
• W2897300980 hasConcept C162356407 @default.
• W2897300980 hasConcept C163127949 @default.
• W2897300980 hasConcept C17525397 @default.
• W2897300980 hasConcept C178790620 @default.
• W2897300980 hasConcept C181199279 @default.
• W2897300980 hasConcept C185592680 @default.
• W2897300980 hasConcept C21951064 @default.
• W2897300980 hasConcept C2777477808 @default.
• W2897300980 hasConcept C43617362 @default.
• W2897300980 hasConcept C52859227 @default.
• W2897300980 hasConcept C538909803 @default.
• W2897300980 hasConcept C55493867 @default.
• W2897300980 hasConcept C68801617 @default.
• W2897300980 hasConceptScore W2897300980C147789679 @default.
• W2897300980 hasConceptScore W2897300980C162356407 @default.
• W2897300980 hasConceptScore W2897300980C163127949 @default.
• W2897300980 hasConceptScore W2897300980C17525397 @default.
• W2897300980 hasConceptScore W2897300980C178790620 @default.
• W2897300980 hasConceptScore W2897300980C181199279 @default.
• W2897300980 hasConceptScore W2897300980C185592680 @default.
• W2897300980 hasConceptScore W2897300980C21951064 @default.
• W2897300980 hasConceptScore W2897300980C2777477808 @default.
• W2897300980 hasConceptScore W2897300980C43617362 @default.
• W2897300980 hasConceptScore W2897300980C52859227 @default.
• W2897300980 hasConceptScore W2897300980C538909803 @default.
• W2897300980 hasConceptScore W2897300980C55493867 @default.
• W2897300980 hasConceptScore W2897300980C68801617 @default.
• W2897300980 hasIssue "8" @default.
• W2897300980 hasLocation W28973009801 @default.
• W2897300980 hasLocation W28973009802 @default.
• W2897300980 hasOpenAccess W2897300980 @default.

• next